These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6857236)

  • 1. Antiviral agents.
    Krenitsky TA; Beauchamp L
    Science; 1983 Jun; 220(4602):1106. PubMed ID: 6857236
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral agents.
    Lefrock JL; Smith BR
    Am Fam Physician; 1983 Jan; 27(1):237-40. PubMed ID: 6297287
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of metabolites of 9-beta-D-arabinofuranosyl-2-fluoroadenine, an antitumor and antiviral agent.
    Struck RF; Shortnacy AT; Kirk MC; Thorpe MC; Brockman RW; Hill DL; El Dareer SM; Montgomery JA
    Biochem Pharmacol; 1982 Jun; 31(11):1975-8. PubMed ID: 7115418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collision induced dissociation studies of alkali metal adducts of tetracyclines and antiviral agents by electrospray ionization, hydrogen/deuterium exchange and multiple stage mass spectrometry.
    Kamel A; Munson B
    Eur J Mass Spectrom (Chichester); 2008; 14(5):281-97. PubMed ID: 19023146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol as an inhibitor of the in vivo formation of acyclovir from desciclovir.
    Krasny HC; Krenitsky TA
    Biochem Pharmacol; 1986 Dec; 35(23):4339-40. PubMed ID: 3790156
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of performance matrix for generic product equivalence of acyclovir topical creams.
    Krishnaiah YS; Xu X; Rahman Z; Yang Y; Katragadda U; Lionberger R; Peters JR; Uhl K; Khan MA
    Int J Pharm; 2014 Nov; 475(1-2):110-22. PubMed ID: 25089511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Etiological therapeutics in viral diseases].
    Brochier B; Thiry E; Wérenne J; Schwers A; Vindevogel H; Pastoret PP
    Ann Rech Vet; 1984; 15(1):35-54. PubMed ID: 6207760
    [No Abstract]   [Full Text] [Related]  

  • 8. Acyclovir--a promising antiviral agent: a review of the preclinical and clinical data in ocular herpes simplex management.
    Koliopoulos J
    Ann Ophthalmol; 1984 Jan; 16(1):19-24. PubMed ID: 6322661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclovir: evaluation of a new antiviral agent.
    Rosenberry KR; Bryan CK; Sohn CA
    Clin Pharm; 1982; 1(5):399-406. PubMed ID: 6307582
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Suzuki M; Okuda T; Shiraki K
    Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Compounds, similar to acyclovir V. Synthesis and antiviral activity of carbethoxyalkoxymethyl derivatives of nucleic bases].
    Shchaveleva IL; Kochetkova SV; Tsilevich TL; Vladyko GV; Korobchenko LV; Boreko EI; Smirnov IP; Khorlin AA; Gottikh BP; Florent'ev VL
    Bioorg Khim; 1989 Jul; 15(7):960-8. PubMed ID: 2818652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus.
    Miwa N; Kurosaki K; Yoshida Y; Kurokawa M; Saito S; Shiraki K
    Antiviral Res; 2005 Jan; 65(1):49-55. PubMed ID: 15652971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in antiviral therapy.
    Deeter RG; Khanderia U
    Clin Pharm; 1986 Dec; 5(12):961-76. PubMed ID: 3542344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation of the antiviral drugs acyclovir and penciclovir in activated sludge treatment.
    Prasse C; Wagner M; Schulz R; Ternes TA
    Environ Sci Technol; 2011 Apr; 45(7):2761-9. PubMed ID: 21388176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs.
    Wada S; Tsuda M; Sekine T; Cha SH; Kimura M; Kanai Y; Endou H
    J Pharmacol Exp Ther; 2000 Sep; 294(3):844-9. PubMed ID: 10945832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New acquisitions in the chemotherapy of viral infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 1990; 52(1):69-99. PubMed ID: 2162118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
    Safrin S; Crumpacker C; Chatis P; Davis R; Hafner R; Rush J; Kessler HA; Landry B; Mills J
    N Engl J Med; 1991 Aug; 325(8):551-5. PubMed ID: 1649971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme.
    Diez-Torrubia A; Cabrera S; de Castro S; García-Aparicio C; Mulder G; De Meester I; Camarasa MJ; Balzarini J; Velázquez S
    Eur J Med Chem; 2013; 70():456-68. PubMed ID: 24185376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antiviral activity of acyclovir loaded into nanoparticles.
    Cavalli R; Donalisio M; Bisazza A; Civra A; Ranucci E; Ferruti P; Lembo D
    Methods Enzymol; 2012; 509():1-19. PubMed ID: 22568898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular penetration of new antiviral agent, hydroxyacyclovir (BW-B759U).
    Schulman J; Peyman GA; Horton MB; Liu J; Barber JC; Fiscella R; de Miranda P
    Jpn J Ophthalmol; 1986; 30(1):116-24. PubMed ID: 3014189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.